<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02292329</url>
  </required_header>
  <id_info>
    <org_study_id>AF1UReading</org_study_id>
    <nct_id>NCT02292329</nct_id>
  </id_info>
  <brief_title>Cardiovascular Benefits of Acai Polyphenols in Volunteers at Risk of Metabolic Syndrome</brief_title>
  <acronym>AF1</acronym>
  <official_title>Cardiovascular Benefits of Acai in Volunteers at Risk of Metabolic Syndrome.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Reading</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Reading</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to carry out a randomized double blind controlled trial in 30
      male subjects to investigate the effect of acai consumption on acute changes in vascular
      function, and to other cardiovascular markers. As a secondary aim the study will allow us to
      characterize the absorption and metabolism of acai polyphenols in humans over a 24 hour
      period.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2014</start_date>
  <completion_date type="Actual">March 2015</completion_date>
  <primary_completion_date type="Actual">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Flow-mediated dilation</measure>
    <time_frame>Change from baseline to 2h</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>plasma polyphenol metabolites</measure>
    <time_frame>Change from baseline to 24h</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">23</enrollment>
  <condition>Cardiovascular Diseases</condition>
  <arm_group>
    <arm_group_label>150g of acai fruit</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>150g of acai fruit in fruit smoothie form</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The control will be a smoothie-like drink matched for major macro- and micro-nutrients</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Acai puree, frozen blended it with banana</intervention_name>
    <description>150g of acai fruit, frozen blended it with banana.</description>
    <arm_group_label>150g of acai fruit</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Control Macronutrient matched</intervention_name>
    <description>Macronutrient matched control in water and also prepared with banana.</description>
    <arm_group_label>Placebo control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male, 30-65 aged, BMI 25-35 kg/m2, Cholesterol &lt;8 mmol/l.

        Exclusion Criteria:

          -  Female, BMI &lt;25 or &gt;35 kg/m2, Cholesterol &gt;8mmol l-1, elevated fasting blood sugar &gt;
             6.5 mmols l-1 , elevated systolic blood pressure &gt;150 mmHg, history of stroke or heart
             attack within the previous 12 months, current smoking, taking lipid lowering, blood
             pressure lowering or anti-blood clotting medication or taking micronutrient
             supplements.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel Commane, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Reading</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hugh Sinclair Unit of Human Nutrition</name>
      <address>
        <city>Reading</city>
        <state>Berkshire</state>
        <zip>RG6 6AP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 24, 2014</study_first_submitted>
  <study_first_submitted_qc>November 12, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 17, 2014</study_first_posted>
  <last_update_submitted>May 27, 2016</last_update_submitted>
  <last_update_submitted_qc>May 27, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 30, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Reading</investigator_affiliation>
    <investigator_full_name>Jeremy Paul Edward Spencer</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>flow-mediated dilation</keyword>
  <keyword>Acai polyphenols</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Metabolic Syndrome X</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

